key: cord-0957068-pblgpxl9
authors: Cosentino, Nicola; Assanelli, Emilio; Merlino, Luca; Mazza, Mario; Bartorelli, Antonio L.; Marenzi, Giancarlo
title: An In-hospital Pathway for Acute Coronary Syndrome Patients During the COVID-19 Outbreak: Initial Experience under Real-world Suboptimal Conditions
date: 2020-04-17
journal: Can J Cardiol
DOI: 10.1016/j.cjca.2020.04.011
sha: 2234d5044e5aeec07f4b20e205c625b03278bb8e
doc_id: 957068
cord_uid: pblgpxl9

Unstructured Abstract In Lombardy (Italy), due to the COVID-19 outbreak, there is an urgent need to manage cardiovascular emergencies, including acute coronary syndrome (ACS), with appropriate standards of care and dedicated preventive measures and pathways against the risk of SARS-CoV-2 infection. For this reason, the Government of Lombardy decided to centralize the treatment of ACS patients in a limited number of centers, including our University Cardiology Institute that in the last four weeks became a cardiovascular emergency referral center in a regional hub and spoke system. Thus, we rapidly developed a customized pathway in order to allocate patients to the appropriate hospital ward, and treat them according to the ACS severity and the risk of suspected SARS-CoV-2 infection. We present here a protocol dedicated to ACS patients adopted in our center since March 13th 2020 and our initial experience in the management of ACS patients during the first four weeks of its use. Certainly, the protocol has room for further improvement as everyone's experience grows, but we hope that it could be a starting point, adaptable to different realities and local resources.

In Lombardy (Italy), due to the COVID-19 outbreak, there is an urgent need to manage cardiovascular emergencies, including acute coronary syndrome (ACS), with appropriate standards of care and dedicated preventive measures and pathways against the risk of SARS-CoV-2 infection.

For this reason, the Government of Lombardy decided to centralize the treatment of ACS patients in a limited number of centers, including our University Cardiology Institute that in the last four weeks became a cardiovascular emergency referral center in a regional hub and spoke system. Thus, we rapidly developed a customized pathway in order to allocate patients to the appropriate hospital ward, and treat them according to the ACS severity and the risk of suspected SARS-CoV-2 infection. We present here a protocol dedicated to ACS patients adopted in our center since March 13 th 2020 and our initial experience in the management of ACS patients during the first four weeks of its use. Certainly, the protocol has room for further improvement as everyone's experience grows, but we hope that it could be a starting point, adaptable to different realities and local resources. 

During COVID-19 pandemic there is an urgent need to manage acute coronary syndrome (ACS) with appropriate standards of care and dedicated preventive measures and pathways against SARS-CoV-2 infection. We present here the pathway dedicated to ACS currently adopted in our center (Milan, Italy) since March 13 th , 2020 and our initial clinical experience during the first four weeks of its use. 4 The uncontained outbreak of coronavirus disease 2019 (COVID-19) has already taken on pandemic proportions. Due to increased demand in Lombardy (Italy), most of the intensive therapy beds, including those of Intensive Cardiac Care Units (ICCU), have been dedicated to the treatment of patients with pneumonia and severe acute respiratory syndrome. 1 At the same time, there is an urgent need to manage cardiovascular emergencies, including acute coronary syndrome (ACS), with appropriate standards of care and dedicated preventive measures and pathways against the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

For this reason, the Government of Lombardy and local health authorities decided to centralize the treatment of cardiovascular emergencies in a limited number of centers, including our University Cardiology Institute that, since four weeks ago, became a referral center for cardiovascular emergencies in a regional hub and spoke system. Thus, we rapidly developed a local protocol for the triage and management of ACS patients. In particular, we conceived a customized pathway in order to allocate patients to the appropriate hospital ward, and treat them according to ACS severity and the risk of suspected SARS-CoV-2 infection. Initially, we have significantly reduced, and in the last four weeks suspended, truly elective procedures in the catheterization laboratories and cardiovascular operating rooms to preserve resources and avoid patient exposure to SARS-CoV-2. Two interventional teams have been dedicated to ACS patients: one working in turn to provide in-hospital 24-hour coverage and the other one being 24-hour on-call. Thus, in the case of an excessive volume of patients, it has been planned to use two catheterization laboratories at the same time and, eventually, additional beds outside the ICCU located in the adjacent post-operative intensive care unit.

We are not sure whether we will be able to keep all protective measures in place while providing best treatment strategies for ACS patients during the uncontained COVID-19 outbreak in Lombardy. However, we believe that our pilot effort may help other hospitals that are already involved with or will have to face the same critical pandemic in the near future. The goal is to guarantee the best and safest treatment to all ACS patients based on the recommendations of the 5 published guidelines, while ensuring in-hospital safety of the healthcare personnel. The figure shows the flow-chart of the ACS protocol currently adopted in our center and we report in the Table   the 

In STEMI patients who are referred to our Emergency Department (ED), conservative care cannot be considered an option in the majority of the cases, and primary percutaneous coronary intervention (PCI) still is our standard of care. Patients, in whom for obvious reason there is not time to wait for nasopharyngeal swab result, are immediately transferred to a catheterization laboratory dedicated only to those potentially infected with SARS-CoV-2 and are subjected to coronary angiography and primary PCI. Notably, despite our catheterization laboratory has about 20 air exchange times per hour, it is not under negative pressure. Therefore, it is sanitized after each procedure by a dry and non-toxic environment micronized disinfecting treatment (PoliDisin TM Air biosteril, Treviso, Italy). After primary PCI, patients are admitted to our 13-bed ICCU within which 5 beds ("red" area) are dedicated to these patients who are considered potentially infected until the result of the diagnostic test. The swab is performed, observing safety rules during specimen collection, as soon as they enter the ICCU and the result is available within 3-4 hours (GeneFinder TM COVID-19 RealAmp Kit, 6 ELITechGroup S.p.A, Torino, Italy). In case of a negative swab result and in the absence of suspicious symptoms of virus infection, the patients are moved from the "red" to the "green" ICCU area and, when the acute phase is over, they are transferred to the ordinary ward where only SARS-CoV-2-negative patients are hospitalized. If the clinical suspicion is high and a second swab remains negative, a chest computed tomography (CT) scan is performed. Conversely, in case of a positive test, they remain in the "red" ICCU area through the acute phase and then are transferred to the ward dedicated only to SARS-CoV-2-positive patients (Figure) . Separate staff of nurses and doctors take care of patients in "red" and "green" ICCU areas. In order to minimize the infection risk within the ICCU "red" area, the following preventive measures are adopted: 1) a single patient room is reserved for patients requiring mechanical ventilation or admitted with an already known SARS-CoV-2-infection; 2) distance of at least two meters between patients separated by a plastic sheet divider; 3) a 1:1 nursing/patient ratio until the swab result is available. Finally, a more rapid (20 minutes) SARS-CoV-2 testing strategy will be available within the next two weeks for early identification of SARS-CoV-2 positive patients, in order to further minimize their stay in the "red" area. As in the catheterization laboratories, ICCU and ordinary ward beds are not under negative pressure. However, they undergo a rapid (30 minutes/100 m 3 ) sanitization after each patient discharge, with the same technology used in the catheterization laboratories.

High-risk NSTE-ACS, as defined by hemodynamic and/or electrical (life-threatening arrhythmias or cardiac arrest) instability, recurrent or ongoing chest pain refractory to medical treatment, and/or relevant ST-T wave changes, follow the STEMI protocol. Patients with NSTE-ACS without the characteristics mentioned above are evaluated in the ED in a dedicated and monitored "red" area and undergo nasopharyngeal swab, and eventually chest CT scan, immediately after ACS diagnosis. The rationale to perform a swab at hospital admission in all patients derives from the high prevalence of asymptomatic patients with SARS-CoV-2 infection in Lombardy who must be isolated. The aim is to reduce the risk of infection spreading within the hospital by keeping separate clinical pathways between SARS-CoV-2-positive and negative patients. In case of a negative test result and absence of suspicious symptoms of virus infection, the patient is transferred to an ordinary monitored ward where only SARS-CoV-2negative patients are hospitalized. Coronary angiography and possibly a PCI are performed within 24 hours in the catheterization laboratory reserved for these patients. On the other hand, when the swab result is positive, the patient is admitted to an ordinary monitored ward dedicated only to SARS-CoV-2-positive patients with a view of deferring the invasive procedure provided she/he has hemodynamic stability. On the contrary, if the invasive approach is considered clinically indicated, the procedure is performed in the catheterization laboratory dedicated to SARS-CoV-2-positive patients.

Initial clinical experience. Ninety-two ACS patients were admitted to our center from March 13 th to April 9 th , 2020 (Table) . Of them, 9 (10%) had a positive SARS-CoV-2 swab at hospital admission or soon after primary PCI, without overt infection symptoms. Only one patient, among those with an initial negative swab, developed symptoms suggestive for COVID-19 during hospitalization and underwent a second swab and CT scan, which both resulted positive. Of note, no death due to COVID-19 occurred during this preliminary experience. The short duration of the observation period prevents conclusions being drawn about the ability of our protocol to reduce the spread of the SARS-CoV-2 infection within the hospital. This will need a much larger sample size with a meticulous nosocomial infection tracking. Similarly, it is premature to make assumptions regarding the cardiac outcome of these patients during the COVID-19 outbreak. However, preliminary experience indicates an overall reduction in the number of patients hospitalized for ACS and their delayed hospital presentation, a phenomenon that is being observed also in other European countries 4 and in the United States 5 . A possible and concerning explanation may be that ACS patients decide to stay at home instead of going to the hospital because COVID-19 has created the fear of being infected in the hospital environment. Unfortunately, when they finally seek 8 medical attention it is often late in the course of the ACS when their condition has worsened.

Supporting this alarming theory is our observation of a higher rate of cardiogenic shock and inhospital cardiac mortality in the last four weeks when compared with the same time interval of the previous year (Table) . If patients delay or avoid care for life-threatening conditions like ACS because of the pandemic fear, then death rate may extend far beyond that directly associated with SARS-CoV-2 infection. This in-hospital pathway focusing on ACS patients is currently ongoing in our center, and we still have no firm data on its effectiveness in containing the spread of the virus within the hospital and ensuring optimal clinical management of ACS patients. To this regard, we acknowledge that our protocol can be considered suboptimal, as it suffers from several physical and technical limitations. An ideal approach would be to have negative pressure facilities and physically separated ICCU beds for SARS-CoV-2 infected and non-infected patients. However, these structural changes cannot be achievable in the short-term in most hospitals worldwide. Indeed, it is noteworthy that, for what concerns negative pressure in the catheterization laboratories, the vast number of them in the United States have either normal or positive ventilation systems because they are not designed for infection isolation. 2 Moreover, we currently lack data comparing our ongoing in-hospital organization for ACS patients with a theoretically optimal one with separated facilities.

It is to be hoped that such data can be obtained in order to determine whether and to what extent major investments are justified.

In conclusion, our protocol has certainly room for significant improvement, as also everyone's experience grows, but we hope that it could be a starting point, adaptable to different realities and local resources. This, with the ultimate goal of maintaining a high level of care for these patients, even at a time of dynamic global crisis that is placing an unprecedented strain on world healthcare systems. 

Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response

American College of Cardiology's (ACC) Interventional Council and the Society of Cardiovascular Angiography and Intervention (SCAI)

Precautions and procedures for coronary and structural cardiac interventions during the COVID-19 pandemic: guidance from Canadian Association of Interventional Cardiology

Impacto de la pandemia de COVID-19 sobre la actividad asistencial en cardiología intervencionista en España. REC Interv Cardiol

Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic

ACS = acute coronary syndrome

= non-ST-elevation acute coronary syndrome

PCI = percutaneous coronary intervention

STEMI = ST-elevation myocardial infarction